Muteins of .beta.-galactosidase fragments having increased activity
AssigneeBoehringer Mannheim GmbH
InventorsScott J. Eisenbeis, Sophie J. Boguslawski, Mark Krevolin, David J. Ledden
Life of this patent
Estimating the term…
Loading patent…
AssigneeBoehringer Mannheim GmbH
InventorsScott J. Eisenbeis, Sophie J. Boguslawski, Mark Krevolin, David J. Ledden
Estimating the term…
Muteins of enzyme acceptor polypeptide fragments of .beta.-galactosidase are provided which exhibit substantially increased kinetic complementation activity with no significant loss in stability. A preferred enzyme acceptor fragment has an amino acid other than cysteine located at position 500 of the natural sequence. An especially preferred substitution is serine or valine. Other preferred muteins have an amino acid other than methionine located at position 443, with leucine being especially preferred, or an amino acid other than cysteine at position 76, with leucine being an especially preferred substitution. Also provided are methods for producing the novel muteins, reagent compositions comprising the novel muteins, and immunoassay methods for determining an analyte in which the novel mutein recombines with an enzyme donor polypeptide fragment to form enzymatically active .beta.-galactosidase.
A mutein of an enzyme acceptor polypeptide of .beta.-galactosidase having an amino acid other than cysteine substituted at position 500.
A mutein of an enzyme acceptor polypeptide of .beta.-galactosidase having an amino acid other than methionine substituted at position 443.
A mutein of an enzyme acceptor polypeptide of .beta.-galactosidase having an amino acid other than cysteine substituted at position 76.
A process for producing a mutein of an enzyme acceptor polypeptide of .beta.-galactosidase said mutein having an amino acid other than cysteine substituted at position 500, comprising providing a starting plasmid comprising a DNA sequence encoding an enzyme acceptor polypeptide of .beta.-galactosidase, causing a site-directed mutation in the portion of said starting plasmid coding for .beta.-galactosidase amino acid 500 which is normally cysteine, thereby forming a mutagenized plasmid, and expressing said mutagenized plasmid to produce said mutein.
A process for producing a mutein of an enzyme acceptor polypeptide of .beta.-galactosidase said mutein having an amino acid other than methionine substituted at position 443, comprising providing a starting plasmid comprising a DNA sequence encoding an enzyme acceptor polypeptide of .beta.-galactosidase, causing a site-directed mutation in the portion of said starting plasmid coding for .beta.-galactosidase amino acid 443 which is normally methionine, and expressing said mutagenized plasmid to produce said mutein.
A process for producing a mutein of an enzyme acceptor polypeptide of .beta.-galactosidase, said mutein having an amino acid other than cysteine substituted at position 76, comprising providing a starting plasmid comprising a DNA sequence encoding an enzyme acceptor polypeptide of .beta.-galactosidase, causing a site-directed mutation in the portion of said starting plasmid coding for .beta.-galactosidase amino acid 76 which is normally cysteine, thereby forming a mutagenized plasmid, and expressing said mutagenized plasmid to produce said mutein.
A reagent composition comprising an enzyme acceptor polypeptide of .beta.-galactosidase having an amino acid other than cysteine substituted at position 500.
A reagent composition comprising an enzyme acceptor polypeptide of .beta.-galactosidase having an amino acid other than methionine substituted at position 443.
A reagent composition comprising an enzyme acceptor polypeptide of .beta.-galactosidase having an amino acid other than cysteine substituted at position 76.
An immunoassay method for determining an analyte in a sample suspected of containing said analyte comprising:
An immunoassay method for determining an analyte in a sample suspected of containing said analyte comprising:
An immunoassay method for determining an analyte in a sample suspected of containing said analyte comprising:
Dependencies are inferred from the claim text.